First Time Loading...

Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.21 AUD Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

SOM Price Targets Summary
Somnomed Ltd

Wall Street analysts forecast SOM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOM is 0.46 AUD with a low forecast of 0.45 AUD and a high forecast of 0.47 AUD.

Lowest
Price Target
0.45 AUD
116% Upside
Average
Price Target
0.46 AUD
119% Upside
Highest
Price Target
0.47 AUD
125% Upside
Somnomed Ltd Competitors:
Price Targets
7716
Nakanishi Inc
37% Upside
AXGN
AxoGen Inc
110% Upside
OSSR
Ossur hf
22% Upside
1302
LifeTech Scientific Corp
95% Upside
SRDX
Surmodics Inc
130% Upside
DIA
DiaSorin SpA
2% Upside
AMPLI
Amplitude Surgical SA
42% Upside
688581
Hangzhou AGS MedTech Co Ltd
91% Upside

Revenue
Forecast

Revenue Estimate
Somnomed Ltd

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 12%. The projected CAGR for the next 3 years is 11%.

12%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SOM's stock price target?
Price Target
0.46 AUD

According to Wall Street analysts, the average 1-year price target for SOM is 0.46 AUD with a low forecast of 0.45 AUD and a high forecast of 0.47 AUD.

What is Somnomed Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 12%. The projected CAGR for the next 3 years is 11%.